These products are not intended for administration to humans or animals, are not approved drugs, and are not intended for the diagnosis, treatment, cure, or prevention of any disease or medical condition
Yes, injection site reactions such as redness, itching, swelling, and mild pain are classified as common, affecting up to 1 in 10 people
Unlike IGF-1 DES, which benefits from site-specific injection, LR3's long half-life means injection site matters less, the peptide will circulate systemically regardless of where you inject it
Key Takeaways: What Women Need to Know About CJC-1295/Ipamorelin Growth hormone production starts declining at 35, not at menopause